Twist Bioscience Corporation TWST Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $110.72M+19.3% | $103.7M+16.9% | $99.01M+16.9% | $96.06M+17.9% | $92.79M+23.2% | ||
| $53.59M+14.6% | $49.73M+8.4% | $48.17M+3.6% | $44.76M-3.1% | $46.77M+5.3% | ||
| $57.12M+24.1% | $53.97M+26.0% | $50.84M+33.0% | $51.3M+45.4% | $46.03M+49.0% | ||
| 51.6%+2.0pp | 52%+3.8pp | 51.3%+6.2pp | 53.4%+10.1pp | 49.6%+8.6pp | ||
| $19.7M-17.7% | $17.13M-19.6% | $17.01M-19.5% | $18.05M-19.7% | $23.92M-1.0% | ||
| $76.09M+19.5% | $69.74M+24.1% | $63.76M+20.0% | $63.37M+11.6% | $63.67M+14.5% | ||
| $156.58M+16.5% | $136.6M+10.7% | $128.94M+6.8% | $126.18M-25.9% | $134.35M+8.2% | ||
| -$45.86M-10.4% | -$32.9M+5.0% | -$29.93M+16.9% | -$30.12M+66.1% | -$41.56M+15.0% | ||
| -41.4%+3.4pp | -31.7%+7.3pp | -30.2%+12.3pp | -31.4%+77.8pp | -44.8%+20.1pp | ||
| $1.71M-39.0% | $2.18M-32.9% | $2.63M-27.3% | $2.69M-26.6% | $2.8M-28.9% | ||
| $175K+144% | $471K+606% | —— | -$836K-591% | -$394K-98.0% | ||
| -$43.98M-12.3% | -$30.25M+3.9% | -$26.88M+22.6% | $20.58M+124% | -$39.15M+13.3% | ||
| $43K-75.4% | $253K+161% | $257K— | $191K0.0% | $175K-49.3% | ||
| -$44.02M-11.9% | -$30.51M+3.4% | -$27.14M+21.7% | $20.39M+124% | -$39.33M+13.5% | ||
| -39.8%+2.6pp | -29.4%+6.2pp | -27.4%+13.5pp | 21.2%+126pp | -42.4%+18.0pp | ||
| -$0.71-7.6% | -$0.50+5.7% | -$0.45+23.7% | $0.33+122% | -$0.66+16.5% | ||
| -$0.71-7.6% | -$0.50+5.7% | -$0.45+23.7% | $0.34+123% | -$0.66+16.5% | ||
| 61.7M+3.4% | 61.1M+3.2% | 59.8M+3.1% | 61.2M+5.2% | 59.6M+3.2% | ||
| 61.7M+3.4% | 61.1M+3.2% | 59.8M+3.1% | 60M+3.2% | 59.6M+3.2% | ||
| -$44.09M-12.1% | -$30.45M+4.0% | -$26.9M+21.9% | $20.19M+124% | -$39.32M+13.7% | ||
| $7.21M— | —— | —— | —— | $0— | ||
| $17K+168% | $38K+162% | —— | -$177K-228% | -$25K+34.2% | ||
| -$85K-383% | $18K+127% | —— | -$25K-19.0% | $30K+153% | ||
| $175K+144% | $471K+606% | —— | -$836K-591% | -$394K-98.0% | ||
| -$45.86M-10.4% | -$32.9M+5.0% | -$29.93M+16.9% | -$30.12M+66.1% | -$41.56M+15.0% | ||
| -$39.45M-12.2% | -$26.71M+5.5% | -$23.93M+18.6% | -$24.06M+70.2% | -$35.16M+13.4% | ||
| -$39.45M-12.2% | -$26.71M+5.5% | -$23.93M+18.6% | -$24.06M+70.2% | -$35.16M+13.4% | ||
| -35.6%+2.3pp | -25.8%+6.1pp | -24.2%+10.5pp | -25%+73.9pp | -37.9%+16.0pp | ||
| -$45.86M-10.4% | -$32.9M+5.0% | -$29.93M+16.9% | -$30.12M+66.1% | -$41.56M+15.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Twist Bioscience Corporation's revenue?
- Twist Bioscience Corporation (TWST) generated $409.5M in revenue over the trailing twelve months, up 17.8% year over year.
- Is Twist Bioscience Corporation profitable?
- Twist Bioscience Corporation is not currently profitable: it reported a net loss of $81.3M over the trailing twelve months, a -19.8% net margin.
- What are Twist Bioscience Corporation's profit margins?
- Gross margin is 52.1% and operating margin is -33.9%, with a -19.8% net margin.
- What is Twist Bioscience Corporation's earnings per share?
- Twist Bioscience Corporation's diluted EPS over the trailing twelve months is $-1.33.
- Where does Twist Bioscience Corporation's income statement data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
